PRHSX Mutual Fund

NAV$91.32

Returns Overview

1 Month
+8.74%
3 Months
+14.39%
6 Months
+7.25%
YTD
+7.23%
1 Year
+30.14%
3 Years (annualized)
+7.60%
5 Years (annualized)
+2.72%
10 Years (annualized)
+11.07%

Risk Metrics (1-Year)

No risk data available for this Mutual Fund

Stress Test Scenarios

How would PRHSX have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

Loading chart data...

3 Months Performance

Loading chart data...

6 Months Performance

Loading chart data...

1 Year Performance

Loading chart data...

Benchmark & Peers

Benchmark
Lipper Health/Biotechnology Funds Index
This Mutual Fund (YTD)
+7.23%
Peer Avg (YTD)
+7.57%
vs Peers
-0.34%

PRHSX Mutual Fund Performance

PRHSX performance across multiple time periods: 1-month 8.74%, YTD 7.23%, 1-year 30.14%, 3-year 7.60%, 5-year 2.72%, 10-year 11.07%.

PRHSX returns trail the peer average of 7.57% YTD. With an expense ratio of 0.80%, investors should weigh costs against performance when evaluating this mutual fund.

PRHSX performance comparison shows side-by-side returns with another fund. PRHSX alternatives are available in the Mutual Fund Screener.